January 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI and ML, and increasing demand for personalized medicine. ...
November 01, 2025
The infant biometric market is expanding due to growing birth rates as well as rising demand for infant identification systems. North America led the market due to the presence of a well-developed healthcare sector....
November 01, 2025
The market is growing due to the strong clinical success of BCMS-targeted therapies and rising cases of relapsed or refractory patients. Improved regulatory support and expanded treatment access are further accelerating market adoption. ...
November 01, 2025
The next-generation AI in life sciences market is growing rapidly due to a growing focus on providing high-quality healthcare services in less time. North America’s dominance is attributed to the rising focus on evidence-based healthcare practices, which can be achieved in less time with generative AI....
November 01, 2025
Advantages of ML in drug discovery, including raised efficiency and prediction rates, are accelerating the drug discovery process as growing cases of various diseases are fueling the expansion of the market across the world. Whereas North America dominated the market due to escalating funding and investments in AI and ML-powered drug discovery by p...
November 01, 2025
Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer occurrence as well as growing drug discoveries for chronic diseases. North America led the market d...
November 01, 2025
The drug discovery SaaS platforms market is growing as mainly used in the drug discovery process for virtual screening, data management and analysis, AI-powered drug design, facilitating collaboration, clinical trial optimization, drug repurposing, target identification, and predicting drug efficacy and toxicity. North America is dominated in the m...
November 01, 2025
The computer-aided drug design (CADD) market is primarily driven by the increasing need for developing new drugs. The growing new drug discovery research and technological advancements drive the market. North America led the global market owing to the presence of key players and increasing investments....
November 01, 2025
Market insights predict the global cellular reprogramming tools industry will increase from USD 456.1 million in 2024 to USD 760.1 million by 2034, achieving a CAGR of 5.24%. The market is growing due to rising demand for regenerative medicine and personalized therapies. Advancements in gene editing and cell reprogramming technologies are further a...
November 01, 2025
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com